This article was originally published in The Tan Sheet
FDA requests comments on existing requirements that infant formula manufacturers notify FDA if their products are found to "not provide the nutrients required" or if the products are adulterated or misbranded. In these instances, the agency evaluates the risk of the problem and may require a recall. The request for comments on the proposed extension of the reporting requirements for infant formula is required under the Paperwork Reduction Act. Comments are due April 26
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC